TSPO-specific ligand Vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation

The promise of anti-inflammatory therapies for CNS injuries and diseases

(2011) Serge Rivest   Expert Review of Neurotherapeutics

Decreased cGMP Level Contributes to Increased Contraction in Arteries From Hypertensive Rats

(2011) Fernanda R. Giachini et al.   HYPERTENSION

Inflammation in neurodegenerative diseases

(2010) Sandra Amor et al.   IMMUNOLOGY

Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions

(2010) B. Rossi et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease

(2010) Lih-Fen Lue et al.   MOLECULAR NEUROBIOLOGY

Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

(2010) Rainer Rupprecht et al.   NATURE REVIEWS DRUG DISCOVERY

Microglia in neurodegenerative disease

(2010) V. Hugh Perry et al.   Nature Reviews Neurology

Vinpocetine as a potent antiinflammatory agent

(2010) A. E. Medina   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vinpocetine inhibits NF- B-dependent inflammation via an IKK-dependent but PDE-independent mechanism

(2010) K.-I. Jeon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Translocator protein (18 kDa) TSPO: An emerging therapeutic target in neurotrauma

(2009) Vassilios Papadopoulos et al.   EXPERIMENTAL NEUROLOGY

Role of microglia in neuronal degeneration and regeneration

(2009) Lisa Walter et al.   Seminars in Immunopathology

Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair

(2008) Ming-Kai Chen et al.   PHARMACOLOGY & THERAPEUTICS